nodes	percent_of_prediction	percent_of_DWPC	metapath
Acitretin—Retinoids—Tazarotene—psoriasis	0.573	1	CiPCiCtD
Acitretin—RARG—Tazarotene—psoriasis	0.0862	0.268	CbGbCtD
Acitretin—RARB—Tazarotene—psoriasis	0.0762	0.237	CbGbCtD
Acitretin—RARA—Tazarotene—psoriasis	0.0762	0.237	CbGbCtD
Acitretin—RXRB—Tazarotene—psoriasis	0.0762	0.237	CbGbCtD
Acitretin—ALB—Mycophenolate mofetil—psoriasis	0.00289	0.00898	CbGbCtD
Acitretin—ALB—Prednisone—psoriasis	0.00231	0.00718	CbGbCtD
Acitretin—ALB—Methotrexate—psoriasis	0.00116	0.0036	CbGbCtD
Acitretin—RARG—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000236	0.00774	CbGpPWpGaD
Acitretin—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CARM1—psoriasis	0.000229	0.00751	CbGpPWpGaD
Acitretin—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000228	0.00746	CbGpPWpGaD
Acitretin—RXRG—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000216	0.00708	CbGpPWpGaD
Acitretin—RXRA—Activation of gene expression by SREBF (SREBP)—CARM1—psoriasis	0.000215	0.00706	CbGpPWpGaD
Acitretin—RARB—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000212	0.00694	CbGpPWpGaD
Acitretin—RARG—Nuclear Receptors—PPARG—psoriasis	0.000208	0.00683	CbGpPWpGaD
Acitretin—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000204	0.00669	CbGpPWpGaD
Acitretin—RARA—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000203	0.00666	CbGpPWpGaD
Acitretin—RXRB—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000203	0.00666	CbGpPWpGaD
Acitretin—RBP1—Retinoblastoma (RB) in Cancer—PCNA—psoriasis	0.000202	0.00664	CbGpPWpGaD
Acitretin—RXRA—Transcriptional activation of mitochondrial biogenesis—CARM1—psoriasis	0.000196	0.00642	CbGpPWpGaD
Acitretin—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000196	0.00642	CbGpPWpGaD
Acitretin—RXRG—Nuclear Receptors—PPARG—psoriasis	0.000191	0.00625	CbGpPWpGaD
Acitretin—RARB—Nuclear Receptors—PPARG—psoriasis	0.000187	0.00612	CbGpPWpGaD
Acitretin—RXRA—The citric acid (TCA) cycle and respiratory electron transport—NDUFA5—psoriasis	0.000183	0.006	CbGpPWpGaD
Acitretin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—VDR—psoriasis	0.000181	0.00595	CbGpPWpGaD
Acitretin—RXRB—Nuclear Receptors—PPARG—psoriasis	0.000179	0.00587	CbGpPWpGaD
Acitretin—RARA—Nuclear Receptors—PPARG—psoriasis	0.000179	0.00587	CbGpPWpGaD
Acitretin—RXRA—Regulation of Androgen receptor activity—REL—psoriasis	0.000175	0.00572	CbGpPWpGaD
Acitretin—RXRA—Regulation of Androgen receptor activity—CARM1—psoriasis	0.000172	0.00563	CbGpPWpGaD
Acitretin—RXRA—Regulation of cholesterol biosynthesis by SREBP (SREBF)—CARM1—psoriasis	0.000172	0.00563	CbGpPWpGaD
Acitretin—RBP1—Diseases associated with visual transduction—APOE—psoriasis	0.00017	0.00558	CbGpPWpGaD
Acitretin—RXRA—Mitochondrial biogenesis—CARM1—psoriasis	0.000169	0.00555	CbGpPWpGaD
Acitretin—RXRA—Circadian Clock—CARM1—psoriasis	0.000167	0.00547	CbGpPWpGaD
Acitretin—RXRA—Transcription factor regulation in adipogenesis—LEP—psoriasis	0.000166	0.00544	CbGpPWpGaD
Acitretin—RARG—Nuclear Receptor transcription pathway—PPARG—psoriasis	0.000165	0.0054	CbGpPWpGaD
Acitretin—RXRA—Retinoic acid receptors-mediated signaling—VDR—psoriasis	0.000162	0.0053	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.00016	0.00526	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.000154	0.00504	CbGpPWpGaD
Acitretin—RXRG—Nuclear Receptor transcription pathway—PPARG—psoriasis	0.000151	0.00494	CbGpPWpGaD
Acitretin—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—psoriasis	0.00015	0.00491	CbGpPWpGaD
Acitretin—RARB—Nuclear Receptor transcription pathway—PPARG—psoriasis	0.000148	0.00484	CbGpPWpGaD
Acitretin—CYP26A1—Adipogenesis—SOCS1—psoriasis	0.000146	0.00479	CbGpPWpGaD
Acitretin—RXRA—Transcription factor regulation in adipogenesis—PPARG—psoriasis	0.000145	0.00474	CbGpPWpGaD
Acitretin—RXRB—Nuclear Receptor transcription pathway—PPARG—psoriasis	0.000142	0.00464	CbGpPWpGaD
Acitretin—RARA—Nuclear Receptor transcription pathway—PPARG—psoriasis	0.000142	0.00464	CbGpPWpGaD
Acitretin—RXRA—Biological oxidations—CYP2S1—psoriasis	0.000137	0.0045	CbGpPWpGaD
Acitretin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TNF—psoriasis	0.000137	0.00449	CbGpPWpGaD
Acitretin—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—psoriasis	0.000134	0.00441	CbGpPWpGaD
Acitretin—RXRA—Nuclear Receptors—VDR—psoriasis	0.000134	0.00439	CbGpPWpGaD
Acitretin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—psoriasis	0.000129	0.00422	CbGpPWpGaD
Acitretin—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—psoriasis	0.000129	0.00422	CbGpPWpGaD
Acitretin—RXRA—Transcriptional regulation of white adipocyte differentiation—CARM1—psoriasis	0.000128	0.00418	CbGpPWpGaD
Acitretin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—psoriasis	0.000127	0.00415	CbGpPWpGaD
Acitretin—RXRG—Adipogenesis—SOCS1—psoriasis	0.000111	0.00363	CbGpPWpGaD
Acitretin—CYP26A1—Adipogenesis—LEP—psoriasis	0.000108	0.00354	CbGpPWpGaD
Acitretin—RXRA—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000106	0.00347	CbGpPWpGaD
Acitretin—RARG—Gene Expression—TARS—psoriasis	0.000105	0.00343	CbGpPWpGaD
Acitretin—RARA—Adipogenesis—SOCS1—psoriasis	0.000104	0.00341	CbGpPWpGaD
Acitretin—RXRG—Regulation of Androgen receptor activity—JUN—psoriasis	0.000104	0.00339	CbGpPWpGaD
Acitretin—ALB—HDL-mediated lipid transport—APOE—psoriasis	0.000103	0.00337	CbGpPWpGaD
Acitretin—RXRA—Orphan transporters—CARM1—psoriasis	0.0001	0.00329	CbGpPWpGaD
Acitretin—RXRB—Regulation of Androgen receptor activity—JUN—psoriasis	9.74e-05	0.00319	CbGpPWpGaD
Acitretin—RXRA—PPARA activates gene expression—CARM1—psoriasis	9.59e-05	0.00314	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—TARS—psoriasis	9.56e-05	0.00313	CbGpPWpGaD
Acitretin—CYP26A1—Adipogenesis—PPARG—psoriasis	9.4e-05	0.00308	CbGpPWpGaD
Acitretin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	9.38e-05	0.00307	CbGpPWpGaD
Acitretin—RARB—Gene Expression—TARS—psoriasis	9.38e-05	0.00307	CbGpPWpGaD
Acitretin—RXRA—Nuclear Receptors—PPARG—psoriasis	9.34e-05	0.00306	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—TARS—psoriasis	8.99e-05	0.00295	CbGpPWpGaD
Acitretin—RARA—Gene Expression—TARS—psoriasis	8.99e-05	0.00295	CbGpPWpGaD
Acitretin—RXRG—Adipogenesis—LEP—psoriasis	8.18e-05	0.00268	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	8.02e-05	0.00263	CbGpPWpGaD
Acitretin—RARA—Adipogenesis—LEP—psoriasis	7.69e-05	0.00252	CbGpPWpGaD
Acitretin—RXRA—Organelle biogenesis and maintenance—CARM1—psoriasis	7.69e-05	0.00252	CbGpPWpGaD
Acitretin—RXRA—Transcription factor regulation in adipogenesis—TNF—psoriasis	7.68e-05	0.00252	CbGpPWpGaD
Acitretin—RXRA—NRF2 pathway—TGFA—psoriasis	7.64e-05	0.0025	CbGpPWpGaD
Acitretin—RBP1—Retinoblastoma (RB) in Cancer—TP53—psoriasis	7.45e-05	0.00244	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—NDUFA5—psoriasis	7.44e-05	0.00244	CbGpPWpGaD
Acitretin—RXRA—Nuclear Receptor transcription pathway—PPARG—psoriasis	7.38e-05	0.00242	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—HCAR2—psoriasis	7.17e-05	0.00235	CbGpPWpGaD
Acitretin—RXRG—Adipogenesis—PPARG—psoriasis	7.13e-05	0.00233	CbGpPWpGaD
Acitretin—RARG—Generic Transcription Pathway—CARM1—psoriasis	6.83e-05	0.00224	CbGpPWpGaD
Acitretin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—psoriasis	6.72e-05	0.0022	CbGpPWpGaD
Acitretin—RARA—Adipogenesis—PPARG—psoriasis	6.7e-05	0.0022	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	6.54e-05	0.00214	CbGpPWpGaD
Acitretin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	6.46e-05	0.00212	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—CYP2S1—psoriasis	6.32e-05	0.00207	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	6.27e-05	0.00205	CbGpPWpGaD
Acitretin—RXRG—Generic Transcription Pathway—CARM1—psoriasis	6.25e-05	0.00205	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TAGAP—psoriasis	6.22e-05	0.00204	CbGpPWpGaD
Acitretin—RXRA—Transcription factor regulation in adipogenesis—IL6—psoriasis	6.2e-05	0.00203	CbGpPWpGaD
Acitretin—RARB—Generic Transcription Pathway—CARM1—psoriasis	6.13e-05	0.00201	CbGpPWpGaD
Acitretin—RXRA—Transcriptional regulation of white adipocyte differentiation—LEP—psoriasis	6.09e-05	0.002	CbGpPWpGaD
Acitretin—ALB—Lipoprotein metabolism—APOE—psoriasis	5.91e-05	0.00194	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—CARM1—psoriasis	5.88e-05	0.00193	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—CARM1—psoriasis	5.88e-05	0.00193	CbGpPWpGaD
Acitretin—CYP26A1—Adipogenesis—STAT3—psoriasis	5.77e-05	0.00189	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	5.49e-05	0.0018	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—SOCS1—psoriasis	5.43e-05	0.00178	CbGpPWpGaD
Acitretin—RXRA—Transcriptional regulation of white adipocyte differentiation—PPARG—psoriasis	5.31e-05	0.00174	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	5.27e-05	0.00173	CbGpPWpGaD
Acitretin—RXRA—Regulation of Androgen receptor activity—JUN—psoriasis	5.08e-05	0.00166	CbGpPWpGaD
Acitretin—CYP26A1—Adipogenesis—TNF—psoriasis	4.99e-05	0.00164	CbGpPWpGaD
Acitretin—ALB—Hemostasis—SERPINB8—psoriasis	4.82e-05	0.00158	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—TARS—psoriasis	4.69e-05	0.00154	CbGpPWpGaD
Acitretin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—psoriasis	4.6e-05	0.00151	CbGpPWpGaD
Acitretin—RXRG—Adipogenesis—STAT3—psoriasis	4.37e-05	0.00143	CbGpPWpGaD
Acitretin—RARA—Adipogenesis—STAT3—psoriasis	4.11e-05	0.00135	CbGpPWpGaD
Acitretin—RARG—Generic Transcription Pathway—VDR—psoriasis	4.08e-05	0.00134	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—CAT—psoriasis	4.05e-05	0.00133	CbGpPWpGaD
Acitretin—CYP26A1—Adipogenesis—IL6—psoriasis	4.03e-05	0.00132	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—LEP—psoriasis	4.01e-05	0.00131	CbGpPWpGaD
Acitretin—RXRA—PPARA activates gene expression—PPARG—psoriasis	3.99e-05	0.00131	CbGpPWpGaD
Acitretin—ALB—Vitamin B12 Metabolism—CRP—psoriasis	3.95e-05	0.00129	CbGpPWpGaD
Acitretin—ALB—Lipid and lipoprotein metabolism—APOE—psoriasis	3.93e-05	0.00129	CbGpPWpGaD
Acitretin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	3.91e-05	0.00128	CbGpPWpGaD
Acitretin—ALB—Vitamin B12 Metabolism—APOE—psoriasis	3.86e-05	0.00127	CbGpPWpGaD
Acitretin—RXRG—Adipogenesis—TNF—psoriasis	3.78e-05	0.00124	CbGpPWpGaD
Acitretin—RXRG—Generic Transcription Pathway—VDR—psoriasis	3.73e-05	0.00122	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CCL20—psoriasis	3.72e-05	0.00122	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—IL4—psoriasis	3.72e-05	0.00122	CbGpPWpGaD
Acitretin—RARB—Generic Transcription Pathway—VDR—psoriasis	3.66e-05	0.0012	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	3.64e-05	0.00119	CbGpPWpGaD
Acitretin—ALB—Vitamin B12 Metabolism—ICAM1—psoriasis	3.63e-05	0.00119	CbGpPWpGaD
Acitretin—RXRA—Transcriptional regulation of white adipocyte differentiation—NFKB1—psoriasis	3.62e-05	0.00119	CbGpPWpGaD
Acitretin—RARA—Adipogenesis—TNF—psoriasis	3.56e-05	0.00117	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—VDR—psoriasis	3.51e-05	0.00115	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—VDR—psoriasis	3.51e-05	0.00115	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	3.51e-05	0.00115	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	3.49e-05	0.00114	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—PPARG—psoriasis	3.49e-05	0.00114	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	3.36e-05	0.0011	CbGpPWpGaD
Acitretin—RARG—Gene Expression—CARM1—psoriasis	3.29e-05	0.00108	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	3.27e-05	0.00107	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—CAT—psoriasis	3.21e-05	0.00105	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—CRP—psoriasis	3.21e-05	0.00105	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	3.18e-05	0.00104	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—CARM1—psoriasis	3.09e-05	0.00101	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—CARM1—psoriasis	3.06e-05	0.001	CbGpPWpGaD
Acitretin—RXRG—Adipogenesis—IL6—psoriasis	3.05e-05	0.001	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	3.05e-05	0.001	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—CARM1—psoriasis	3.01e-05	0.000986	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—ICAM1—psoriasis	2.95e-05	0.000968	CbGpPWpGaD
Acitretin—RARB—Gene Expression—CARM1—psoriasis	2.95e-05	0.000967	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—CARM1—psoriasis	2.88e-05	0.000945	CbGpPWpGaD
Acitretin—RARA—Adipogenesis—IL6—psoriasis	2.87e-05	0.000941	CbGpPWpGaD
Acitretin—RARG—Generic Transcription Pathway—PPARG—psoriasis	2.84e-05	0.000932	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—CARM1—psoriasis	2.83e-05	0.000927	CbGpPWpGaD
Acitretin—RARA—Gene Expression—CARM1—psoriasis	2.83e-05	0.000927	CbGpPWpGaD
Acitretin—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—psoriasis	2.82e-05	0.000924	CbGpPWpGaD
Acitretin—ALB—Vitamin B12 Metabolism—IFNG—psoriasis	2.76e-05	0.000905	CbGpPWpGaD
Acitretin—RXRA—Metabolism—NDUFA5—psoriasis	2.76e-05	0.000905	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.75e-05	0.0009	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	2.73e-05	0.000894	CbGpPWpGaD
Acitretin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	2.69e-05	0.000882	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	2.62e-05	0.000857	CbGpPWpGaD
Acitretin—RXRG—Generic Transcription Pathway—PPARG—psoriasis	2.6e-05	0.000853	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.57e-05	0.000844	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—CP—psoriasis	2.57e-05	0.000841	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—CRP—psoriasis	2.55e-05	0.000836	CbGpPWpGaD
Acitretin—RARB—Generic Transcription Pathway—PPARG—psoriasis	2.55e-05	0.000836	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—CARM1—psoriasis	2.45e-05	0.000802	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—PPARG—psoriasis	2.45e-05	0.000802	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—PPARG—psoriasis	2.45e-05	0.000802	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	2.4e-05	0.000788	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYP2S1—psoriasis	2.35e-05	0.000769	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—ICAM1—psoriasis	2.35e-05	0.000769	CbGpPWpGaD
Acitretin—RBP1—Disease—HLA-A—psoriasis	2.32e-05	0.000759	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	2.31e-05	0.000755	CbGpPWpGaD
Acitretin—ALB—SLC-mediated transmembrane transport—CP—psoriasis	2.3e-05	0.000755	CbGpPWpGaD
Acitretin—ALB—Vitamin B12 Metabolism—NFKB1—psoriasis	2.3e-05	0.000753	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—IFNG—psoriasis	2.25e-05	0.000736	CbGpPWpGaD
Acitretin—RBP1—Disease—APOE—psoriasis	2.16e-05	0.000708	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—STAT3—psoriasis	2.14e-05	0.000702	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—SOCS1—psoriasis	2.05e-05	0.000672	CbGpPWpGaD
Acitretin—RBP1—Disease—NOS2—psoriasis	2.01e-05	0.00066	CbGpPWpGaD
Acitretin—RARG—Gene Expression—VDR—psoriasis	1.96e-05	0.000644	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—CAT—psoriasis	1.9e-05	0.000622	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—NFKB1—psoriasis	1.87e-05	0.000613	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—TNF—psoriasis	1.85e-05	0.000608	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—VDR—psoriasis	1.83e-05	0.000599	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.82e-05	0.000596	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—VDR—psoriasis	1.8e-05	0.000589	CbGpPWpGaD
Acitretin—ALB—Vitamin B12 Metabolism—TNF—psoriasis	1.79e-05	0.000586	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—IFNG—psoriasis	1.79e-05	0.000585	CbGpPWpGaD
Acitretin—RARB—Gene Expression—VDR—psoriasis	1.76e-05	0.000577	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.75e-05	0.000574	CbGpPWpGaD
Acitretin—Decreased appetite—Mycophenolate mofetil—psoriasis	1.74e-05	0.000233	CcSEcCtD
Acitretin—Anorexia—Hydrocortisone—psoriasis	1.74e-05	0.000233	CcSEcCtD
Acitretin—Diarrhoea—Mycophenolic acid—psoriasis	1.74e-05	0.000232	CcSEcCtD
Acitretin—Stomatitis—Methotrexate—psoriasis	1.74e-05	0.000232	CcSEcCtD
Acitretin—Angiopathy—Prednisone—psoriasis	1.74e-05	0.000232	CcSEcCtD
Acitretin—Conjunctivitis—Methotrexate—psoriasis	1.73e-05	0.000231	CcSEcCtD
Acitretin—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	1.73e-05	0.000231	CcSEcCtD
Acitretin—Immune system disorder—Prednisone—psoriasis	1.73e-05	0.000231	CcSEcCtD
Acitretin—Malaise—Betamethasone—psoriasis	1.73e-05	0.000231	CcSEcCtD
Acitretin—Malaise—Dexamethasone—psoriasis	1.73e-05	0.000231	CcSEcCtD
Acitretin—Oedema—Triamcinolone—psoriasis	1.72e-05	0.00023	CcSEcCtD
Acitretin—Pain—Mycophenolate mofetil—psoriasis	1.72e-05	0.000229	CcSEcCtD
Acitretin—Constipation—Mycophenolate mofetil—psoriasis	1.72e-05	0.000229	CcSEcCtD
Acitretin—Infection—Triamcinolone—psoriasis	1.71e-05	0.000229	CcSEcCtD
Acitretin—Haematuria—Methotrexate—psoriasis	1.7e-05	0.000227	CcSEcCtD
Acitretin—Feeling abnormal—Cyclosporine—psoriasis	1.7e-05	0.000227	CcSEcCtD
Acitretin—Insomnia—Prednisolone—psoriasis	1.69e-05	0.000226	CcSEcCtD
Acitretin—Alopecia—Prednisone—psoriasis	1.69e-05	0.000226	CcSEcCtD
Acitretin—RARA—Gene Expression—VDR—psoriasis	1.69e-05	0.000554	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—VDR—psoriasis	1.69e-05	0.000554	CbGpPWpGaD
Acitretin—Gastrointestinal pain—Cyclosporine—psoriasis	1.68e-05	0.000225	CcSEcCtD
Acitretin—Dizziness—Mycophenolic acid—psoriasis	1.68e-05	0.000225	CcSEcCtD
Acitretin—Epistaxis—Methotrexate—psoriasis	1.68e-05	0.000225	CcSEcCtD
Acitretin—Paraesthesia—Prednisolone—psoriasis	1.68e-05	0.000225	CcSEcCtD
Acitretin—Erythema—Prednisone—psoriasis	1.67e-05	0.000223	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Hydrocortisone—psoriasis	1.67e-05	0.000223	CcSEcCtD
Acitretin—Hyperhidrosis—Triamcinolone—psoriasis	1.66e-05	0.000222	CcSEcCtD
Acitretin—Feeling abnormal—Mycophenolate mofetil—psoriasis	1.65e-05	0.000221	CcSEcCtD
Acitretin—Insomnia—Hydrocortisone—psoriasis	1.65e-05	0.000221	CcSEcCtD
Acitretin—RBP1—Disease—TYK2—psoriasis	1.65e-05	0.000541	CbGpPWpGaD
Acitretin—Paraesthesia—Hydrocortisone—psoriasis	1.64e-05	0.000219	CcSEcCtD
Acitretin—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	1.64e-05	0.000219	CcSEcCtD
Acitretin—Urticaria—Cyclosporine—psoriasis	1.63e-05	0.000218	CcSEcCtD
Acitretin—Myalgia—Dexamethasone—psoriasis	1.63e-05	0.000218	CcSEcCtD
Acitretin—Myalgia—Betamethasone—psoriasis	1.63e-05	0.000218	CcSEcCtD
Acitretin—Abdominal pain—Cyclosporine—psoriasis	1.63e-05	0.000217	CcSEcCtD
Acitretin—Body temperature increased—Cyclosporine—psoriasis	1.63e-05	0.000217	CcSEcCtD
Acitretin—Anxiety—Dexamethasone—psoriasis	1.62e-05	0.000217	CcSEcCtD
Acitretin—Anxiety—Betamethasone—psoriasis	1.62e-05	0.000217	CcSEcCtD
Acitretin—Vomiting—Mycophenolic acid—psoriasis	1.62e-05	0.000216	CcSEcCtD
Acitretin—Discomfort—Dexamethasone—psoriasis	1.61e-05	0.000215	CcSEcCtD
Acitretin—Discomfort—Betamethasone—psoriasis	1.61e-05	0.000215	CcSEcCtD
Acitretin—Dyspepsia—Hydrocortisone—psoriasis	1.61e-05	0.000215	CcSEcCtD
Acitretin—Haemoglobin—Methotrexate—psoriasis	1.61e-05	0.000215	CcSEcCtD
Acitretin—Rash—Mycophenolic acid—psoriasis	1.6e-05	0.000214	CcSEcCtD
Acitretin—Dermatitis—Mycophenolic acid—psoriasis	1.6e-05	0.000214	CcSEcCtD
Acitretin—Pain—Prednisolone—psoriasis	1.6e-05	0.000214	CcSEcCtD
Acitretin—Hepatitis—Methotrexate—psoriasis	1.6e-05	0.000214	CcSEcCtD
Acitretin—Haemorrhage—Methotrexate—psoriasis	1.6e-05	0.000214	CcSEcCtD
Acitretin—Urticaria—Mycophenolate mofetil—psoriasis	1.59e-05	0.000213	CcSEcCtD
Acitretin—Headache—Mycophenolic acid—psoriasis	1.59e-05	0.000213	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.59e-05	0.000521	CbGpPWpGaD
Acitretin—Decreased appetite—Hydrocortisone—psoriasis	1.59e-05	0.000212	CcSEcCtD
Acitretin—Pharyngitis—Methotrexate—psoriasis	1.59e-05	0.000212	CcSEcCtD
Acitretin—Abdominal pain—Mycophenolate mofetil—psoriasis	1.59e-05	0.000212	CcSEcCtD
Acitretin—Body temperature increased—Mycophenolate mofetil—psoriasis	1.59e-05	0.000212	CcSEcCtD
Acitretin—Gastrointestinal disorder—Hydrocortisone—psoriasis	1.58e-05	0.000211	CcSEcCtD
Acitretin—Fatigue—Hydrocortisone—psoriasis	1.58e-05	0.000211	CcSEcCtD
Acitretin—Vision blurred—Prednisone—psoriasis	1.57e-05	0.00021	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Triamcinolone—psoriasis	1.57e-05	0.00021	CcSEcCtD
Acitretin—Pain—Hydrocortisone—psoriasis	1.56e-05	0.000209	CcSEcCtD
Acitretin—Oedema—Betamethasone—psoriasis	1.56e-05	0.000209	CcSEcCtD
Acitretin—Oedema—Dexamethasone—psoriasis	1.56e-05	0.000209	CcSEcCtD
Acitretin—Insomnia—Triamcinolone—psoriasis	1.56e-05	0.000208	CcSEcCtD
Acitretin—Infection—Dexamethasone—psoriasis	1.55e-05	0.000207	CcSEcCtD
Acitretin—Infection—Betamethasone—psoriasis	1.55e-05	0.000207	CcSEcCtD
Acitretin—Ill-defined disorder—Prednisone—psoriasis	1.55e-05	0.000207	CcSEcCtD
Acitretin—Paraesthesia—Triamcinolone—psoriasis	1.55e-05	0.000207	CcSEcCtD
Acitretin—Feeling abnormal—Prednisolone—psoriasis	1.54e-05	0.000206	CcSEcCtD
Acitretin—Visual impairment—Methotrexate—psoriasis	1.54e-05	0.000206	CcSEcCtD
Acitretin—Angioedema—Prednisone—psoriasis	1.52e-05	0.000203	CcSEcCtD
Acitretin—Hypersensitivity—Cyclosporine—psoriasis	1.52e-05	0.000203	CcSEcCtD
Acitretin—Dyspepsia—Triamcinolone—psoriasis	1.52e-05	0.000202	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—LEP—psoriasis	1.51e-05	0.000496	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—APOE—psoriasis	1.51e-05	0.000496	CbGpPWpGaD
Acitretin—Nausea—Mycophenolic acid—psoriasis	1.51e-05	0.000202	CcSEcCtD
Acitretin—Hyperhidrosis—Betamethasone—psoriasis	1.51e-05	0.000202	CcSEcCtD
Acitretin—Hyperhidrosis—Dexamethasone—psoriasis	1.51e-05	0.000202	CcSEcCtD
Acitretin—Feeling abnormal—Hydrocortisone—psoriasis	1.51e-05	0.000201	CcSEcCtD
Acitretin—Malaise—Prednisone—psoriasis	1.5e-05	0.000201	CcSEcCtD
Acitretin—RXRA—Adipogenesis—IL6—psoriasis	1.5e-05	0.00049	CbGpPWpGaD
Acitretin—Eye disorder—Methotrexate—psoriasis	1.5e-05	0.0002	CcSEcCtD
Acitretin—Gastrointestinal pain—Hydrocortisone—psoriasis	1.49e-05	0.0002	CcSEcCtD
Acitretin—Tinnitus—Methotrexate—psoriasis	1.49e-05	0.000199	CcSEcCtD
Acitretin—RBP1—Disease—CD4—psoriasis	1.49e-05	0.000489	CbGpPWpGaD
Acitretin—Anorexia—Betamethasone—psoriasis	1.49e-05	0.000199	CcSEcCtD
Acitretin—Anorexia—Dexamethasone—psoriasis	1.49e-05	0.000199	CcSEcCtD
Acitretin—Urticaria—Prednisolone—psoriasis	1.49e-05	0.000199	CcSEcCtD
Acitretin—ALB—Selenium Micronutrient Network—NFKB1—psoriasis	1.49e-05	0.000487	CbGpPWpGaD
Acitretin—Fatigue—Triamcinolone—psoriasis	1.48e-05	0.000198	CcSEcCtD
Acitretin—Hypersensitivity—Mycophenolate mofetil—psoriasis	1.48e-05	0.000198	CcSEcCtD
Acitretin—Asthenia—Cyclosporine—psoriasis	1.48e-05	0.000197	CcSEcCtD
Acitretin—CYP26A1—Metabolism—APOE—psoriasis	1.48e-05	0.000483	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—CARM1—psoriasis	1.47e-05	0.000483	CbGpPWpGaD
Acitretin—Pain—Triamcinolone—psoriasis	1.47e-05	0.000197	CcSEcCtD
Acitretin—Pruritus—Cyclosporine—psoriasis	1.46e-05	0.000194	CcSEcCtD
Acitretin—ALB—Platelet degranulation—VEGFA—psoriasis	1.46e-05	0.000477	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—TNF—psoriasis	1.45e-05	0.000477	CbGpPWpGaD
Acitretin—Urticaria—Hydrocortisone—psoriasis	1.45e-05	0.000194	CcSEcCtD
Acitretin—Angiopathy—Methotrexate—psoriasis	1.45e-05	0.000194	CcSEcCtD
Acitretin—Immune system disorder—Methotrexate—psoriasis	1.45e-05	0.000193	CcSEcCtD
Acitretin—Body temperature increased—Hydrocortisone—psoriasis	1.45e-05	0.000193	CcSEcCtD
Acitretin—Abdominal pain—Hydrocortisone—psoriasis	1.45e-05	0.000193	CcSEcCtD
Acitretin—ALB—Vitamin B12 Metabolism—IL6—psoriasis	1.44e-05	0.000473	CbGpPWpGaD
Acitretin—Asthenia—Mycophenolate mofetil—psoriasis	1.44e-05	0.000192	CcSEcCtD
Acitretin—Chills—Methotrexate—psoriasis	1.44e-05	0.000192	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Dexamethasone—psoriasis	1.42e-05	0.00019	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Betamethasone—psoriasis	1.42e-05	0.00019	CcSEcCtD
Acitretin—Pruritus—Mycophenolate mofetil—psoriasis	1.42e-05	0.00019	CcSEcCtD
Acitretin—Myalgia—Prednisone—psoriasis	1.42e-05	0.00019	CcSEcCtD
Acitretin—Arthralgia—Prednisone—psoriasis	1.42e-05	0.00019	CcSEcCtD
Acitretin—Feeling abnormal—Triamcinolone—psoriasis	1.42e-05	0.00019	CcSEcCtD
Acitretin—Anxiety—Prednisone—psoriasis	1.41e-05	0.000189	CcSEcCtD
Acitretin—Alopecia—Methotrexate—psoriasis	1.41e-05	0.000189	CcSEcCtD
Acitretin—Insomnia—Dexamethasone—psoriasis	1.41e-05	0.000189	CcSEcCtD
Acitretin—Insomnia—Betamethasone—psoriasis	1.41e-05	0.000189	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—NFKBIA—psoriasis	1.41e-05	0.000462	CbGpPWpGaD
Acitretin—Diarrhoea—Cyclosporine—psoriasis	1.41e-05	0.000188	CcSEcCtD
Acitretin—Paraesthesia—Dexamethasone—psoriasis	1.4e-05	0.000187	CcSEcCtD
Acitretin—Paraesthesia—Betamethasone—psoriasis	1.4e-05	0.000187	CcSEcCtD
Acitretin—Discomfort—Prednisone—psoriasis	1.4e-05	0.000187	CcSEcCtD
Acitretin—ALB—Hemostasis—ITGAL—psoriasis	1.4e-05	0.000459	CbGpPWpGaD
Acitretin—Erythema—Methotrexate—psoriasis	1.39e-05	0.000186	CcSEcCtD
Acitretin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	1.39e-05	0.000454	CbGpPWpGaD
Acitretin—Hypersensitivity—Prednisolone—psoriasis	1.38e-05	0.000184	CcSEcCtD
Acitretin—RXRA—Developmental Biology—LEP—psoriasis	1.38e-05	0.000451	CbGpPWpGaD
Acitretin—Dyspepsia—Betamethasone—psoriasis	1.37e-05	0.000184	CcSEcCtD
Acitretin—Dyspepsia—Dexamethasone—psoriasis	1.37e-05	0.000184	CcSEcCtD
Acitretin—Diarrhoea—Mycophenolate mofetil—psoriasis	1.37e-05	0.000183	CcSEcCtD
Acitretin—RARG—Gene Expression—PPARG—psoriasis	1.37e-05	0.000449	CbGpPWpGaD
Acitretin—Urticaria—Triamcinolone—psoriasis	1.37e-05	0.000183	CcSEcCtD
Acitretin—Dysgeusia—Methotrexate—psoriasis	1.36e-05	0.000182	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.36e-05	0.000447	CbGpPWpGaD
Acitretin—Body temperature increased—Triamcinolone—psoriasis	1.36e-05	0.000182	CcSEcCtD
Acitretin—Dizziness—Cyclosporine—psoriasis	1.36e-05	0.000182	CcSEcCtD
Acitretin—Oedema—Prednisone—psoriasis	1.36e-05	0.000182	CcSEcCtD
Acitretin—Decreased appetite—Betamethasone—psoriasis	1.36e-05	0.000181	CcSEcCtD
Acitretin—Decreased appetite—Dexamethasone—psoriasis	1.36e-05	0.000181	CcSEcCtD
Acitretin—Infection—Prednisone—psoriasis	1.35e-05	0.000181	CcSEcCtD
Acitretin—Gastrointestinal disorder—Betamethasone—psoriasis	1.35e-05	0.00018	CcSEcCtD
Acitretin—Gastrointestinal disorder—Dexamethasone—psoriasis	1.35e-05	0.00018	CcSEcCtD
Acitretin—Back pain—Methotrexate—psoriasis	1.35e-05	0.00018	CcSEcCtD
Acitretin—Hypersensitivity—Hydrocortisone—psoriasis	1.35e-05	0.00018	CcSEcCtD
Acitretin—Fatigue—Betamethasone—psoriasis	1.35e-05	0.00018	CcSEcCtD
Acitretin—Fatigue—Dexamethasone—psoriasis	1.35e-05	0.00018	CcSEcCtD
Acitretin—Pain—Betamethasone—psoriasis	1.34e-05	0.000178	CcSEcCtD
Acitretin—Pain—Dexamethasone—psoriasis	1.34e-05	0.000178	CcSEcCtD
Acitretin—Dizziness—Mycophenolate mofetil—psoriasis	1.33e-05	0.000177	CcSEcCtD
Acitretin—Skin disorder—Prednisone—psoriasis	1.32e-05	0.000177	CcSEcCtD
Acitretin—Hyperhidrosis—Prednisone—psoriasis	1.31e-05	0.000176	CcSEcCtD
Acitretin—Vision blurred—Methotrexate—psoriasis	1.31e-05	0.000175	CcSEcCtD
Acitretin—Asthenia—Hydrocortisone—psoriasis	1.31e-05	0.000175	CcSEcCtD
Acitretin—Vomiting—Cyclosporine—psoriasis	1.31e-05	0.000175	CcSEcCtD
Acitretin—Rash—Cyclosporine—psoriasis	1.3e-05	0.000173	CcSEcCtD
Acitretin—Anorexia—Prednisone—psoriasis	1.3e-05	0.000173	CcSEcCtD
Acitretin—Dermatitis—Cyclosporine—psoriasis	1.3e-05	0.000173	CcSEcCtD
Acitretin—Pruritus—Hydrocortisone—psoriasis	1.29e-05	0.000173	CcSEcCtD
Acitretin—Ill-defined disorder—Methotrexate—psoriasis	1.29e-05	0.000173	CcSEcCtD
Acitretin—Headache—Cyclosporine—psoriasis	1.29e-05	0.000172	CcSEcCtD
Acitretin—Feeling abnormal—Dexamethasone—psoriasis	1.29e-05	0.000172	CcSEcCtD
Acitretin—Feeling abnormal—Betamethasone—psoriasis	1.29e-05	0.000172	CcSEcCtD
Acitretin—CYP26A1—Metabolism—PPARG—psoriasis	1.29e-05	0.000421	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—TP53—psoriasis	1.28e-05	0.00042	CbGpPWpGaD
Acitretin—Gastrointestinal pain—Betamethasone—psoriasis	1.28e-05	0.000171	CcSEcCtD
Acitretin—Gastrointestinal pain—Dexamethasone—psoriasis	1.28e-05	0.000171	CcSEcCtD
Acitretin—Vomiting—Mycophenolate mofetil—psoriasis	1.28e-05	0.00017	CcSEcCtD
Acitretin—RXRA—Generic Transcription Pathway—PPARG—psoriasis	1.27e-05	0.000418	CbGpPWpGaD
Acitretin—Hypersensitivity—Triamcinolone—psoriasis	1.27e-05	0.000169	CcSEcCtD
Acitretin—Rash—Mycophenolate mofetil—psoriasis	1.27e-05	0.000169	CcSEcCtD
Acitretin—Dermatitis—Mycophenolate mofetil—psoriasis	1.26e-05	0.000169	CcSEcCtD
Acitretin—ALB—Metabolism—NDUFA5—psoriasis	1.26e-05	0.000413	CbGpPWpGaD
Acitretin—Headache—Mycophenolate mofetil—psoriasis	1.26e-05	0.000168	CcSEcCtD
Acitretin—Malaise—Methotrexate—psoriasis	1.26e-05	0.000168	CcSEcCtD
Acitretin—RXRG—Gene Expression—PPARG—psoriasis	1.25e-05	0.00041	CbGpPWpGaD
Acitretin—Diarrhoea—Hydrocortisone—psoriasis	1.25e-05	0.000167	CcSEcCtD
Acitretin—Urticaria—Betamethasone—psoriasis	1.24e-05	0.000166	CcSEcCtD
Acitretin—Urticaria—Dexamethasone—psoriasis	1.24e-05	0.000166	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Prednisone—psoriasis	1.24e-05	0.000166	CcSEcCtD
Acitretin—Dizziness—Prednisolone—psoriasis	1.24e-05	0.000165	CcSEcCtD
Acitretin—Asthenia—Triamcinolone—psoriasis	1.24e-05	0.000165	CcSEcCtD
Acitretin—Body temperature increased—Dexamethasone—psoriasis	1.23e-05	0.000165	CcSEcCtD
Acitretin—Abdominal pain—Betamethasone—psoriasis	1.23e-05	0.000165	CcSEcCtD
Acitretin—Body temperature increased—Betamethasone—psoriasis	1.23e-05	0.000165	CcSEcCtD
Acitretin—Abdominal pain—Dexamethasone—psoriasis	1.23e-05	0.000165	CcSEcCtD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.23e-05	0.000403	CbGpPWpGaD
Acitretin—Insomnia—Prednisone—psoriasis	1.23e-05	0.000164	CcSEcCtD
Acitretin—RARB—Gene Expression—PPARG—psoriasis	1.23e-05	0.000403	CbGpPWpGaD
Acitretin—Nausea—Cyclosporine—psoriasis	1.22e-05	0.000163	CcSEcCtD
Acitretin—Paraesthesia—Prednisone—psoriasis	1.22e-05	0.000163	CcSEcCtD
Acitretin—Pruritus—Triamcinolone—psoriasis	1.22e-05	0.000163	CcSEcCtD
Acitretin—Cough—Methotrexate—psoriasis	1.22e-05	0.000162	CcSEcCtD
Acitretin—Dizziness—Hydrocortisone—psoriasis	1.21e-05	0.000162	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.2e-05	0.000394	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—PPARG—psoriasis	1.2e-05	0.000393	CbGpPWpGaD
Acitretin—Dyspepsia—Prednisone—psoriasis	1.2e-05	0.00016	CcSEcCtD
Acitretin—Nausea—Mycophenolate mofetil—psoriasis	1.19e-05	0.000159	CcSEcCtD
Acitretin—Myalgia—Methotrexate—psoriasis	1.19e-05	0.000158	CcSEcCtD
Acitretin—Chest pain—Methotrexate—psoriasis	1.19e-05	0.000158	CcSEcCtD
Acitretin—Arthralgia—Methotrexate—psoriasis	1.19e-05	0.000158	CcSEcCtD
Acitretin—Decreased appetite—Prednisone—psoriasis	1.18e-05	0.000158	CcSEcCtD
Acitretin—Rash—Prednisolone—psoriasis	1.18e-05	0.000158	CcSEcCtD
Acitretin—Dermatitis—Prednisolone—psoriasis	1.18e-05	0.000158	CcSEcCtD
Acitretin—RARA—Gene Expression—PPARG—psoriasis	1.18e-05	0.000386	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—PPARG—psoriasis	1.18e-05	0.000386	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.17e-05	0.000385	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—IL6—psoriasis	1.17e-05	0.000385	CbGpPWpGaD
Acitretin—Fatigue—Prednisone—psoriasis	1.17e-05	0.000157	CcSEcCtD
Acitretin—Headache—Prednisolone—psoriasis	1.17e-05	0.000157	CcSEcCtD
Acitretin—Discomfort—Methotrexate—psoriasis	1.17e-05	0.000157	CcSEcCtD
Acitretin—ALB—Transmembrane transport of small molecules—CP—psoriasis	1.17e-05	0.000383	CbGpPWpGaD
Acitretin—Constipation—Prednisone—psoriasis	1.16e-05	0.000155	CcSEcCtD
Acitretin—Vomiting—Hydrocortisone—psoriasis	1.16e-05	0.000155	CcSEcCtD
Acitretin—ALB—Selenium Micronutrient Network—TNF—psoriasis	1.16e-05	0.000379	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TYK2—psoriasis	1.16e-05	0.000379	CbGpPWpGaD
Acitretin—RBP1—Disease—STAT3—psoriasis	1.16e-05	0.000378	CbGpPWpGaD
Acitretin—Rash—Hydrocortisone—psoriasis	1.15e-05	0.000154	CcSEcCtD
Acitretin—Dermatitis—Hydrocortisone—psoriasis	1.15e-05	0.000154	CcSEcCtD
Acitretin—RXRA—Metabolism—CARM1—psoriasis	1.15e-05	0.000376	CbGpPWpGaD
Acitretin—Headache—Hydrocortisone—psoriasis	1.15e-05	0.000153	CcSEcCtD
Acitretin—Dizziness—Triamcinolone—psoriasis	1.14e-05	0.000152	CcSEcCtD
Acitretin—Infection—Methotrexate—psoriasis	1.13e-05	0.000151	CcSEcCtD
Acitretin—Feeling abnormal—Prednisone—psoriasis	1.12e-05	0.00015	CcSEcCtD
Acitretin—Asthenia—Betamethasone—psoriasis	1.12e-05	0.00015	CcSEcCtD
Acitretin—Asthenia—Dexamethasone—psoriasis	1.12e-05	0.00015	CcSEcCtD
Acitretin—ALB—Transmembrane transport of small molecules—CARM1—psoriasis	1.12e-05	0.000366	CbGpPWpGaD
Acitretin—Gastrointestinal pain—Prednisone—psoriasis	1.11e-05	0.000149	CcSEcCtD
Acitretin—Nausea—Prednisolone—psoriasis	1.11e-05	0.000149	CcSEcCtD
Acitretin—Pruritus—Dexamethasone—psoriasis	1.11e-05	0.000148	CcSEcCtD
Acitretin—Pruritus—Betamethasone—psoriasis	1.11e-05	0.000148	CcSEcCtD
Acitretin—Skin disorder—Methotrexate—psoriasis	1.1e-05	0.000148	CcSEcCtD
Acitretin—Hyperhidrosis—Methotrexate—psoriasis	1.1e-05	0.000147	CcSEcCtD
Acitretin—Vomiting—Triamcinolone—psoriasis	1.09e-05	0.000146	CcSEcCtD
Acitretin—Nausea—Hydrocortisone—psoriasis	1.09e-05	0.000145	CcSEcCtD
Acitretin—Rash—Triamcinolone—psoriasis	1.09e-05	0.000145	CcSEcCtD
Acitretin—Dermatitis—Triamcinolone—psoriasis	1.08e-05	0.000145	CcSEcCtD
Acitretin—Anorexia—Methotrexate—psoriasis	1.08e-05	0.000145	CcSEcCtD
Acitretin—Urticaria—Prednisone—psoriasis	1.08e-05	0.000144	CcSEcCtD
Acitretin—Headache—Triamcinolone—psoriasis	1.08e-05	0.000144	CcSEcCtD
Acitretin—Abdominal pain—Prednisone—psoriasis	1.08e-05	0.000144	CcSEcCtD
Acitretin—Body temperature increased—Prednisone—psoriasis	1.08e-05	0.000144	CcSEcCtD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.07e-05	0.000351	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP2S1—psoriasis	1.07e-05	0.000351	CbGpPWpGaD
Acitretin—Diarrhoea—Dexamethasone—psoriasis	1.07e-05	0.000143	CcSEcCtD
Acitretin—Diarrhoea—Betamethasone—psoriasis	1.07e-05	0.000143	CcSEcCtD
Acitretin—RXRA—Developmental Biology—TYK2—psoriasis	1.05e-05	0.000345	CbGpPWpGaD
Acitretin—Musculoskeletal discomfort—Methotrexate—psoriasis	1.04e-05	0.000138	CcSEcCtD
Acitretin—Dizziness—Dexamethasone—psoriasis	1.03e-05	0.000138	CcSEcCtD
Acitretin—Dizziness—Betamethasone—psoriasis	1.03e-05	0.000138	CcSEcCtD
Acitretin—Insomnia—Methotrexate—psoriasis	1.03e-05	0.000137	CcSEcCtD
Acitretin—Nausea—Triamcinolone—psoriasis	1.02e-05	0.000137	CcSEcCtD
Acitretin—Paraesthesia—Methotrexate—psoriasis	1.02e-05	0.000136	CcSEcCtD
Acitretin—Somnolence—Methotrexate—psoriasis	1.01e-05	0.000135	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—CXCL8—psoriasis	1.01e-05	0.00033	CbGpPWpGaD
Acitretin—Hypersensitivity—Prednisone—psoriasis	1e-05	0.000134	CcSEcCtD
Acitretin—Dyspepsia—Methotrexate—psoriasis	1e-05	0.000134	CcSEcCtD
Acitretin—Vomiting—Betamethasone—psoriasis	9.93e-06	0.000133	CcSEcCtD
Acitretin—Vomiting—Dexamethasone—psoriasis	9.93e-06	0.000133	CcSEcCtD
Acitretin—Decreased appetite—Methotrexate—psoriasis	9.88e-06	0.000132	CcSEcCtD
Acitretin—Rash—Betamethasone—psoriasis	9.85e-06	0.000132	CcSEcCtD
Acitretin—Rash—Dexamethasone—psoriasis	9.85e-06	0.000132	CcSEcCtD
Acitretin—Dermatitis—Dexamethasone—psoriasis	9.84e-06	0.000131	CcSEcCtD
Acitretin—Dermatitis—Betamethasone—psoriasis	9.84e-06	0.000131	CcSEcCtD
Acitretin—Gastrointestinal disorder—Methotrexate—psoriasis	9.81e-06	0.000131	CcSEcCtD
Acitretin—Fatigue—Methotrexate—psoriasis	9.8e-06	0.000131	CcSEcCtD
Acitretin—Headache—Dexamethasone—psoriasis	9.78e-06	0.000131	CcSEcCtD
Acitretin—Headache—Betamethasone—psoriasis	9.78e-06	0.000131	CcSEcCtD
Acitretin—Asthenia—Prednisone—psoriasis	9.76e-06	0.00013	CcSEcCtD
Acitretin—Pain—Methotrexate—psoriasis	9.72e-06	0.00013	CcSEcCtD
Acitretin—Pruritus—Prednisone—psoriasis	9.62e-06	0.000129	CcSEcCtD
Acitretin—Feeling abnormal—Methotrexate—psoriasis	9.37e-06	0.000125	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—JUN—psoriasis	9.35e-06	0.000306	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—IL6—psoriasis	9.32e-06	0.000306	CbGpPWpGaD
Acitretin—Diarrhoea—Prednisone—psoriasis	9.31e-06	0.000124	CcSEcCtD
Acitretin—Gastrointestinal pain—Methotrexate—psoriasis	9.3e-06	0.000124	CcSEcCtD
Acitretin—Nausea—Dexamethasone—psoriasis	9.28e-06	0.000124	CcSEcCtD
Acitretin—Nausea—Betamethasone—psoriasis	9.28e-06	0.000124	CcSEcCtD
Acitretin—Urticaria—Methotrexate—psoriasis	9.03e-06	0.000121	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—NFKB1—psoriasis	9e-06	0.000295	CbGpPWpGaD
Acitretin—Dizziness—Prednisone—psoriasis	8.99e-06	0.00012	CcSEcCtD
Acitretin—Body temperature increased—Methotrexate—psoriasis	8.99e-06	0.00012	CcSEcCtD
Acitretin—Abdominal pain—Methotrexate—psoriasis	8.99e-06	0.00012	CcSEcCtD
Acitretin—RXRA—Gene Expression—VDR—psoriasis	8.8e-06	0.000288	CbGpPWpGaD
Acitretin—Vomiting—Prednisone—psoriasis	8.65e-06	0.000116	CcSEcCtD
Acitretin—Rash—Prednisone—psoriasis	8.58e-06	0.000115	CcSEcCtD
Acitretin—Dermatitis—Prednisone—psoriasis	8.57e-06	0.000114	CcSEcCtD
Acitretin—Headache—Prednisone—psoriasis	8.52e-06	0.000114	CcSEcCtD
Acitretin—Hypersensitivity—Methotrexate—psoriasis	8.38e-06	0.000112	CcSEcCtD
Acitretin—RXRA—Developmental Biology—NFKB1—psoriasis	8.19e-06	0.000268	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—VEGFA—psoriasis	8.17e-06	0.000268	CbGpPWpGaD
Acitretin—Asthenia—Methotrexate—psoriasis	8.16e-06	0.000109	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—STAT3—psoriasis	8.09e-06	0.000265	CbGpPWpGaD
Acitretin—Nausea—Prednisone—psoriasis	8.08e-06	0.000108	CcSEcCtD
Acitretin—RBP1—Disease—IL6—psoriasis	8.07e-06	0.000264	CbGpPWpGaD
Acitretin—Pruritus—Methotrexate—psoriasis	8.04e-06	0.000107	CcSEcCtD
Acitretin—Diarrhoea—Methotrexate—psoriasis	7.78e-06	0.000104	CcSEcCtD
Acitretin—Dizziness—Methotrexate—psoriasis	7.52e-06	0.0001	CcSEcCtD
Acitretin—RXRA—Developmental Biology—VEGFA—psoriasis	7.44e-06	0.000244	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—STAT3—psoriasis	7.36e-06	0.000241	CbGpPWpGaD
Acitretin—Vomiting—Methotrexate—psoriasis	7.23e-06	9.66e-05	CcSEcCtD
Acitretin—Rash—Methotrexate—psoriasis	7.17e-06	9.58e-05	CcSEcCtD
Acitretin—Dermatitis—Methotrexate—psoriasis	7.16e-06	9.57e-05	CcSEcCtD
Acitretin—Headache—Methotrexate—psoriasis	7.12e-06	9.52e-05	CcSEcCtD
Acitretin—RXRA—Metabolism—CAT—psoriasis	7.05e-06	0.000231	CbGpPWpGaD
Acitretin—Nausea—Methotrexate—psoriasis	6.75e-06	9.02e-05	CcSEcCtD
Acitretin—ALB—Platelet activation, signaling and aggregation—VEGFA—psoriasis	6.45e-06	0.000211	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—TNF—psoriasis	6.37e-06	0.000209	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TP53—psoriasis	6.17e-06	0.000202	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—PPARG—psoriasis	6.14e-06	0.000201	CbGpPWpGaD
Acitretin—ALB—Hemostasis—NOS2—psoriasis	5.74e-06	0.000188	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IL6—psoriasis	5.65e-06	0.000185	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.61e-06	0.000184	CbGpPWpGaD
Acitretin—RXRA—Metabolism—APOE—psoriasis	5.48e-06	0.00018	CbGpPWpGaD
Acitretin—ALB—Metabolism—CARM1—psoriasis	5.23e-06	0.000171	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—IL6—psoriasis	5.14e-06	0.000169	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.89e-06	0.00016	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PPARG—psoriasis	4.77e-06	0.000156	CbGpPWpGaD
Acitretin—ALB—Hemostasis—VEGFA—psoriasis	3.33e-06	0.000109	CbGpPWpGaD
Acitretin—ALB—Metabolism—CAT—psoriasis	3.22e-06	0.000105	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TP53—psoriasis	2.51e-06	8.24e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—APOE—psoriasis	2.5e-06	8.19e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PPARG—psoriasis	2.18e-06	7.13e-05	CbGpPWpGaD
